Crossmark

Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist

Crossref DOI link: https://doi.org/10.1007/s40262-018-0668-z

Published Online: 2018-06-19

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hall, Sylvie

Isaacs, Diana

Clements, Jennifer N.
License Information

Text and Data Mining valid from 2018-06-19
More Information

Article History

First Online: 19 June 2018

Compliance with Ethical Standards

:

: No external funding was used in the preparation of this manuscript.

: Sylvie Hall, Diana Isaacs, and Jennifer N. Clements declare they have no conflicts of interest that might be relevant to the contents of this manuscript.